Trucept Inc.

Afinida, Inc., a Trucept company, recently filed its 2024 financial statement and the results are in: a net increase of $3.3 million in revenues and a gross profit increase of more than $1 million over the previous year, not to mention a massive reduction in outstanding payable balances.

https://bit.ly/4lc5NQG

Trucept Inc.’s Afinida Reports Increase of Nearly $3.3 Million in Net Revenues for 2024 - Trucept, Inc. Afinida reports a 17% revenue increase in 2024, driven by strategic investments in new operating subsidiaries. Gross profit rose 8% while accounts payable dropped 70%.

Trucept’s Afinida just filed its annual financial statement and announced a 17% revenue increase (nearly $3.3 million) in 2024, due to strategic investments in new operating subsidiaries.

Read the press release: https://bit.ly/4lc5NQG

🎯 Another strong quarter! Q3 2024 sees substantial increases in revenues and profits, setting the stage for a successful close to the year. Cheers to our team and leadership for driving our ongoing success!

Read more: https://bit.ly/4fvZNiM